Ceres Acquisition Kapitalrendite
Was ist das Kapitalrendite von Ceres Acquisition?
Kapitalrendite von Ceres Acquisition Corp. ist -102.54%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Finance Sektor auf OTC im Vergleich zu Ceres Acquisition
Was macht Ceres Acquisition?
Ceres Acquisition Corp. does not have significant operations. It focuses on identifying and evaluating opportunities for the acquisition of assets or business with a view to completing a qualifying transaction. The company intends to identify business opportunities in the field of the cannabis industry. Ceres Acquisition Corp. was incorporated in 2020 and is headquartered in Los Angeles, California.
Unternehmen mit kapitalrendite ähnlich Ceres Acquisition
- NeuroVive Pharmaceutical AB hat Kapitalrendite von -102.71%
- ECMOHO Ltd hat Kapitalrendite von -102.70%
- Total Brain hat Kapitalrendite von -102.69%
- Alector hat Kapitalrendite von -102.63%
- Unique Fabricating Inc hat Kapitalrendite von -102.60%
- The Fertilisers And Chemicals Travancore hat Kapitalrendite von -102.60%
- Ceres Acquisition hat Kapitalrendite von -102.54%
- Dacian Gold hat Kapitalrendite von -102.54%
- Atomera Inc hat Kapitalrendite von -102.30%
- SkinBioTherapeutics Plc hat Kapitalrendite von -102.27%
- Payright hat Kapitalrendite von -102.25%
- Sensorion SAS hat Kapitalrendite von -102.25%
- ReTo Eco-Solutions Inc hat Kapitalrendite von -102.22%